期刊文献+

76例系统性硬化症临床特征分析 被引量:1

下载PDF
导出
摘要 目的探讨系统性硬化症(SSc)患者的临床特征。方法回顾性分析76例SSc患者的临床资料。结果(1)流行病学:男女比例为1︰3.75;年龄(57.41±12.12)岁;弥漫型SSc 54例,局限型SSc 17例,重叠综合征4例,CREST 1例。(2)临床表现:1首发症状主要为雷诺现象(41例)、皮肤硬肿(23例)。2累及内脏以肺间质纤维化(PIF)(44例)、关节受累(29例)、消化道损害(18例)最常见。3PIF中11例无呼吸系统的临床症状,为常规筛查时发现。25例肺动脉高压(PAH)中9例无临床症状。(3)实验室检查:抗核抗体阳性67例,抗拓扑异构酶I抗体(Scl-70)阳性35例,抗着丝点抗体(ACA)阳性24例,见Scl-70及ACA同时阳性者1例。抗Scl-70抗体阳性者有较高水平的免疫球蛋白Ig M(=0.033),较低水平的Ig G(=0.041),存在ACA阳性的患者关节受累及肺间质病变少见(=0.035、0.014)。(4)影像学检查:间质性肺炎/肺纤维化影像学表现以磨玻璃样、网格状多见,Scl-70阳性者以磨玻璃样病变多见(=0.049)。结论 SSc患者皮肤外脏器受累并不少见,尤其是肺间质病变,因此早期进行自身抗体的检测及相关辅助检查可提高对SSc的诊断率及治疗水平。
机构地区 宁波市第一医院
出处 《现代实用医学》 2015年第8期989-990,共2页 Modern Practical Medicine
  • 相关文献

参考文献7

  • 1Gabrielli A, Avvedimento EV, Krieg T. Scleroderma[J].N Engl J Med,2009,360 (19):1989-2003.
  • 2Meyer OC, Fertig N, Lueas M, et al. Dis- ease subsets, antinuclear antibody profile, and clinical features in 127 French and 247 US adult patients with systemic scler- osis[J]. J Rheumatol,2007,34(1 ): 104-109.
  • 3Walker UA, Tyndall A, Czirj& L, et al. Clinical risk assessment of organ manifes-tations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Re- search group database[J].Ann Rheum Dis, 2007,66(6):754-763.
  • 4Christmann RB, Wells AU, Capelozzi VL, et al. Gastroesophageal reflux incites interstitial lung disease in systemic scler- osis: clinical, radiologic, histopathologic, and treatment evidence[J].Semin Arthritis Rheum,2010,40(3):241-249.
  • 5Demir N, Ahin A, KiiOkahin O, et al. Pul- monary arterial hypertension and systemic sclerosis relation: a single centre exper- ience[J]. Heart Lung Circ,2014,23(7): 667-673.
  • 6王迁,徐东,李梦涛,侯勇,白伊娜,胡朝军,宋宁,赵久良,张奉春,赵岩,曾小峰.硬皮病相关自身抗体谱与中国系统性硬化患者临床相关性分析[J].北京医学,2010,32(7):499-503. 被引量:13
  • 7Koenig M, Dieude M, Seneal JL. Predic- tive value of antinuclear autoantibodies: the lessons of the systemic sclerosis auto- antibodies [J].Autoimmun Rev,2008,7(8): 588-593.

二级参考文献11

  • 1郭敏骅,屠文震.系统性硬皮病抗U_1RNP抗体的检测及其临床意义[J].临床皮肤科杂志,2005,34(12):812-813. 被引量:3
  • 2Gabrielli A, Awedimento EV, Krieg T. Scleroderma. N Engl J Med, 2009, 360:1989-2003.
  • 3Meyer OC, Fertig N, Lucas M, et al. Disease subsets, antinuclear antibody profile, and clinical features in 127 French and 247 US adult patients with systemic sclerosis. J Rheumatol, 2007, 34: 104-109.
  • 4Walker UA, Tyndall A, Czirjok L, et al. Geographical variation of disease manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials and Research (EUSTAR) group database. Ann Rheum Dis, 2009, 68:856-862.
  • 5Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum, 1980, 23:581-590.
  • 6Clements P, Lachenbruch P, Seibold J, et al. Inter- and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol, 1995, 22:1281-1285.
  • 7Koenig M, Dieude M, Senecal JL. Predictive value of antinuelear autoantibodies: The lessons of the systemic sclerosis autoantibodies. Autoimmun Rev, 2008,7:588-593.
  • 8Santiago M, Baron M, Hudson M, et al. Antibodies to RNA polymerase Ⅲ in systemic sclerosis detected by ELISA. J Rheumatol, 2007, 34:1528-1534.
  • 9Cavazzana I, Angela C, Paolo A, et al. Anti-RNA polymerase Ⅲ antibodies: A marker of systemic sclerosis with rapid onset and skin thickening progression. Autoimmun Rev, 2009, 8:580-584.
  • 10詹克勤,吴杰敏,洪志海.弥漫型硬皮病抗DNA拓扑异构酶I抗体的检测及临床意义[J].实验与检验医学,2008,26(6):615-616. 被引量:1

共引文献12

同被引文献4

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部